NDC 70534-001

Paclitaxel

Paclitaxel

Paclitaxel is a Intravenous Injection, Powder, Lyophilized, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Hbt Labs, Inc.. The primary component is Paclitaxel.

Product ID70534-001_0c51fd28-42c2-4584-9c40-91945cd26810
NDC70534-001
Product TypeHuman Prescription Drug
Proprietary NamePaclitaxel
Generic NamePaclitaxel
Dosage FormInjection, Powder, Lyophilized, For Suspension
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-09-27
Marketing CategoryNDA /
Application NumberNDA211875
Labeler NameHBT Labs, Inc.
Substance NamePACLITAXEL
Active Ingredient Strength100 mg/20mL
Pharm ClassesMicrotubule Inhibition [PE], Microtubule Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 70534-001-00

1 VIAL in 1 CARTON (70534-001-00) > 20 mL in 1 VIAL
Marketing Start Date2022-09-27
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Paclitaxel" or generic name "Paclitaxel"

NDCBrand NameGeneric Name
0703-3213PaclitaxelPaclitaxel
0703-3216PaclitaxelPaclitaxel
0703-3217PaclitaxelPaclitaxel
0703-3218PaclitaxelPaclitaxel
0703-4764PaclitaxelPaclitaxel
0703-4766PaclitaxelPaclitaxel
0703-4767PaclitaxelPaclitaxel
0703-4768PaclitaxelPaclitaxel
16714-137PaclitaxelPaclitaxel
16729-098PaclitaxelPACLITAXEL
44567-504PaclitaxelPaclitaxel
44567-505PaclitaxelPaclitaxel
44567-506PaclitaxelPaclitaxel
45963-613PaclitaxelPaclitaxel
47781-593Paclitaxelpaclitaxel
70860-200PaclitaxelPaclitaxel
47781-595PaclitaxelPaclitaxel
47781-594PaclitaxelPaclitaxel
51991-938PaclitaxelPaclitaxel
51991-937PaclitaxelPaclitaxel
51991-936PaclitaxelPaclitaxel
61703-342PaclitaxelPaclitaxel
63323-763PaclitaxelPaclitaxel
67457-449PaclitaxelPaclitaxel
67457-434PaclitaxelPaclitaxel
67457-471PaclitaxelPaclitaxel
70860-215PaclitaxelPaclitaxel
24979-710Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)Paclitaxel

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.